CN106421045A - Medicine for treating arthritis, rheumatism and metabolic arthritis and preparing method thereof - Google Patents
Medicine for treating arthritis, rheumatism and metabolic arthritis and preparing method thereof Download PDFInfo
- Publication number
- CN106421045A CN106421045A CN201610946765.3A CN201610946765A CN106421045A CN 106421045 A CN106421045 A CN 106421045A CN 201610946765 A CN201610946765 A CN 201610946765A CN 106421045 A CN106421045 A CN 106421045A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- herba
- arthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 206010003246 arthritis Diseases 0.000 title claims abstract description 22
- 229940079593 drug Drugs 0.000 title claims description 8
- 230000002503 metabolic effect Effects 0.000 title abstract description 4
- 238000000034 method Methods 0.000 title abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract 3
- 201000005569 Gout Diseases 0.000 claims description 16
- 210000000582 semen Anatomy 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 12
- 241000628997 Flos Species 0.000 claims description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 8
- 241000180649 Panax notoginseng Species 0.000 claims description 8
- 241000271039 Agkistrodon Species 0.000 claims description 6
- 239000012467 final product Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 241000345998 Calamus manan Species 0.000 claims description 3
- 235000012950 rattan cane Nutrition 0.000 claims description 3
- 239000004575 stone Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 8
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract 2
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 235000015784 Artemisia rupestris Nutrition 0.000 abstract 1
- 241001670235 Artemisia rupestris Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 244000306301 Caesalpinia sappan Species 0.000 abstract 1
- 235000015162 Caesalpinia sappan Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241001050741 Dipsacus asperoides Species 0.000 abstract 1
- 241000501743 Gentiana macrophylla Species 0.000 abstract 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 abstract 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241000488974 Loranthus Species 0.000 abstract 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 241000753128 Periploca <moth> Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 241000270295 Serpentes Species 0.000 abstract 1
- 102000011842 Serrate-Jagged Proteins Human genes 0.000 abstract 1
- 108010036039 Serrate-Jagged Proteins Proteins 0.000 abstract 1
- 244000107975 Strychnos nux-vomica Species 0.000 abstract 1
- 229940023019 aconite Drugs 0.000 abstract 1
- 244000237330 gutta percha tree Species 0.000 abstract 1
- 238000005070 sampling Methods 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 238000005303 weighing Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229960003444 immunosuppressant agent Drugs 0.000 description 2
- 230000001861 immunosuppressant effect Effects 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 229960002170 azathioprine Drugs 0.000 description 1
- LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000002356 skeleton Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating arthritis, rheumatism and metabolic arthritis and a preparing method thereof. The medicine is prepared from, by weight, 8-12 parts of nux vomica, 10-14 parts of aconite root, 10-14 parts of radix aconiti, 13-17 parts of artemisia rupestris, 18-22 parts of Caulis Spatholobi, 8-12 parts of cassia twig, 8-12 parts of frutus aurantii, 13-17 parts of peach kernel, 8-12 parts of red flower, 13-17 parts of caesalpinia sappan, 8-12parts of angelica sinensis, 13-17 parts of Ligusticum wallichii, 13-17 parts of root of common peony, 8-12 parts of radix bupleuri, 8-12 parts of fructus liquidambaris, 8-12 parts of lignum phetimiae, 5-7 parts of asarum sieboldi mig., 8-12 parts of gentiana macrophylla, 13-17 parts of dipsacus asperoides, 8-12 parts of eucommia ulmoides, 13-17 parts of pseudo-ginseng, 8-12 parts of loranthus, 8-12 parts of glycyrrhiza uralensis, 3 snakes, 18-22 parts of herba chloranthi serrate, 18-22 parts of periploca forrestii schltr and 13-17 parts of the root of Divaricate Saposhnikovia Root. The preparing method comprises the steps of sifting bulk pharmaceutical chemicals, and weighing and taking samplings according to a weight ratio; soaking the bulk pharmaceutical chemicals obtained in the last step with alcohol strength being 70-80 degrees for 4-6 days, and finally obtaining the medicine. The obtained medicine has good curative effects on arthritis, rheumatism and metabolic arthritis. Besides, the medicine has rich medicinal resources, low price and no side effects; meanwhile, the preparing method is simple and easy to operate. The medicine has 300 cases of clinical treatment, and the total effective rate is 90%. In addition, all the cases have no untoward effects.
Description
Technical field
The invention belongs to pharmaceutical technology field, relate in particular to the medicine of a kind for the treatment of of arthritis, rheumatism, gout, with
When further relate to its preparation method.
Background technology
Arthritis refer to the inflammatory diseasess occurring in human synovial and its surrounding tissue, can be divided into tens of kinds.The pass of China
The scorching patient of section has more than 100,000,000, and number is being continuously increased.Clinical manifestation be joint red, swollen, hot, bitterly, dysfunction and joint
Deformity, severe patient leads to joint deformity, impact patients ' life quality.The arthritic cause of disease is complicated, main and inflammation, autoimmune
The factors such as reaction, infection, metabolism disorder, wound, degeneration are relevant.
Rheumatism is one group and invades joint, skeleton, muscle, blood vessel and about the disease based on soft tissue or connective tissue,
Wherein most is autoimmune disease.Morbidity is much more hidden and slow, and the course of disease is longer, and mostly has genetic predisposition.Diagnosis
And treatment all acquires a certain degree of difficulty；How different autoantibodys can be checked in blood, may be relevant from different HLA hypotypes；To non-
Steroidal anti-inflammatory drugs (NSAID), glucocorticoid and immunosuppressant have preferable short-term or the reaction of long-term palliative.
Gout is that purine metabolic disturbance causes the metabolic disease that uric acid synthesis increases and leads to.Clinical manifestation：Acute pain
Show as the serious pain of affected joints, swelling, erythema, stiff, heating, and symptom during wind outbreak to occur suddenly.Market now
Though this quasi drugs upper are many, most pain relievings are of short duration, and effect is slow and unstable.
Current Therapeutic Method, the medicine of employing has nonsteroidal antiinflammatory drug, Salicylic Acid Formulations, indomethacin, propanoic acid to spread out
Biology, and immunosuppressant azathioprine, cyclophosphamide, methotrexate etc..It is excellent that Western medicine has rapid-action, good analgesic effect etc.
Point, but side effect is larger, long-term taking has infringement to hepatic and renal function, and it is unstable to take Chinese Herbs, easily recurs.
Content of the invention
It is an object of the invention to provide a kind of cheap, effect is significant, and have no side effect treatment of arthritis, wind
Wet, gout medicine.
Another object of the present invention is to providing the preparation method of this medicine.
A kind for the treatment of of arthritis of the present invention, rheumatism, the medicine of gout, by weight, including following raw material：
Semen Strychni 8-12 part, Radix Aconiti 10-14 part, Radix Aconiti Kusnezoffii 10-14 part, Herba Achilleae 13-17 part, Caulis Spatholobi 18-22 part, Ramulus Cinnamomi
8-12 part, Fructus Aurantii 8-12 part, Semen Persicae 13-17 part, Flos Carthami 8-12 part, Lignum Sappan 13-17 part, Radix Angelicae Sinensis 8-12 part, Rhizoma Chuanxiong 13-17 part,
Radix Paeoniae Rubra 13-17 part, Radix Bupleuri 8-12 part, Fructus Liquidambaris 8-12 part, Caulis et Folium piperis 8-12 part, Herba Asari 5-7 part, Radix Gentianae Macrophyllae 8-12 part, Radix Dipsaci 13-
17 parts, Cortex Eucommiae 8-12 part, Radix Notoginseng 13-17 part, Herba Taxilli 8-12 part, Radix Glycyrrhizae 8-12 part, Agkistrodon 3, Herba Chloranthi Henryi (Herba Choranthi seu Lysimachiae) 18-22 part,
Heiguteng exract 18-22 part, Radix Saposhnikoviae 13-17 part.
Above-mentioned treatment of arthritis, rheumatism, the medicine of gout, preferably each parts by weight of raw materials is as follows：
10 parts of Semen Strychni, 12 parts of Radix Aconiti, 12 parts of Radix Aconiti Kusnezoffii, 15 parts of Herba Achilleae, 20 parts of Caulis Spatholobi, 10 parts of Ramulus Cinnamomi, 10 parts of Fructus Aurantii,
15 parts of Semen Persicae, 10 parts of Flos Carthami, 15 parts of Lignum Sappan, 10 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Chuanxiong, 15 parts of Radix Paeoniae Rubra, 10 parts of Radix Bupleuri, 10 parts of Fructus Liquidambaris, stone
10 parts of nanmu rattan, 6 parts of Herba Asari, 10 parts of Radix Gentianae Macrophyllae, 15 parts of Radix Dipsaci, 10 parts of the Cortex Eucommiae, 15 parts of Radix Notoginseng, 10 parts of Herba Taxilli, 10 parts of Radix Glycyrrhizae, spend in vain
Serpentiss 2-4 bar, 20 parts of Herba Chloranthi Henryi (Herba Choranthi seu Lysimachiae), 20 parts of Heiguteng exract, 15 parts of Radix Saposhnikoviae.
A kind for the treatment of of arthritis of the present invention, rheumatism, the preparation method of the medicine of gout, comprise the following steps：
（1）Screening crude drug, samples by weight ratio；
（2）With alcohol-pickled 4-6 days of 2300-2700 part 70-80 degree, obtain final product.
A kind of above-mentioned treatment of arthritis, rheumatism, the preparation method of the medicine of gout, wherein step（2）Described in wine
Essence is 75 degree.
The present invention compared with prior art, has obvious beneficial effect, as can be known from the above technical solutions：The present invention selects horse
Semen Strychni, Radix Aconiti, Radix Aconiti Kusnezoffii, Herba Achilleae, Caulis Spatholobi, Ramulus Cinnamomi, Fructus Aurantii, Semen Persicae, Flos Carthami, Lignum Sappan, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae Rubra, bavin
Recklessly, Fructus Liquidambaris, Caulis et Folium piperis, Herba Asari, Radix Gentianae Macrophyllae, Radix Dipsaci, the Cortex Eucommiae, Radix Notoginseng, Herba Taxilli, Radix Glycyrrhizae, Agkistrodon, Herba Chloranthi Henryi (Herba Choranthi seu Lysimachiae), Heiguteng exract, anti-
Wind is raw material, plays effect of reducing swelling and alleviating pain, expelling wind and cold by the synergism of each medicine.Arthritis, rheumatism, gout are had
Good therapeutical effect.Medicine source is abundant, cheap, have no side effect, and preparation method is simple, easily operated.Clinical treatment disease
Example 300, total effective rate 90%.All cases all have no adverse reaction.
Specific embodiment
The beneficial effect of of the present invention medicine is expanded on further below by way of test example.
Test example：The clinical observation of medicine of the present invention
1st, clinical data
Treatment case 300, wherein：One full year of life at age 30-70, man 100, female 200.
2nd, diagnostic criteria：
《Disease of tcm Standardization of diagnosis and curative effect》.
3rd, Therapeutic Method：
External embodiment of the present invention gained medicine, daily 2-3 time, i.e. effective using 5-7 days.
4th, curative effect determinate standard
Effective：Symptom disappears；
Effectively：Symptom is relieved；
Invalid：Symptom is not improved.
5th, therapeutic outcome：
Patient use medicine of the present invention, effective 220, effective 50, invalid 30, total effective rate 90%.
Illustrate the preparation method of this medicine by following examples.
Embodiment 1：
A kind for the treatment of of arthritis, rheumatism, the preparation method of the medicine of gout, comprise the following steps：
（1）Screening crude drug, weighs Semen Strychni 8g, Radix Aconiti 14g, Radix Aconiti Kusnezoffii 10g, Herba Achilleae 17g, Caulis Spatholobi 18g, Ramulus Cinnamomi
12g, Fructus Aurantii 8g, Semen Persicae 17g, Flos Carthami 8g, Lignum Sappan 17g, Radix Angelicae Sinensis 8g, Rhizoma Chuanxiong 17g, Radix Paeoniae Rubra 13g, Radix Bupleuri 12g, Fructus Liquidambaris 8g, stone
Nanmu rattan 12g, Herba Asari 5g, Radix Gentianae Macrophyllae 12g, Radix Dipsaci 13g, Cortex Eucommiae 12g, Radix Notoginseng 13g, Herba Taxilli 12g, Radix Glycyrrhizae 8g, Agkistrodon 4, four
Block watt 18g, Heiguteng exract 22g, Radix Saposhnikoviae 13g；
（2）With 2.3kg, 80 degree alcohol-pickled 4 days, obtains final product.
Embodiment 2：
A kind for the treatment of of arthritis, rheumatism, the preparation method of the medicine of gout, comprise the following steps：
（1）Screening crude drug, weighs Semen Strychni 10g, Radix Aconiti 12g, Radix Aconiti Kusnezoffii 12g, Herba Achilleae 15g, Caulis Spatholobi 20g, Ramulus Cinnamomi
10g, Fructus Aurantii 10g, Semen Persicae 15g, Flos Carthami 10g, Lignum Sappan 15g, Radix Angelicae Sinensis 10g, Rhizoma Chuanxiong 15g, Radix Paeoniae Rubra 15g, Radix Bupleuri 10g, Fructus Liquidambaris
10g, Caulis et Folium piperis 10g, Herba Asari 6g, Radix Gentianae Macrophyllae 10g, Radix Dipsaci 15g, Cortex Eucommiae 10g, Radix Notoginseng 15g, Herba Taxilli 10g, Radix Glycyrrhizae 10g, Agkistrodon
Article 3, Herba Chloranthi Henryi (Herba Choranthi seu Lysimachiae) 20g, Heiguteng exract 20g, Radix Saposhnikoviae 15g；
（2）With 2.5kg, 75 degree alcohol-pickled 5 days, obtains final product.
Embodiment 3：
A kind for the treatment of of arthritis, rheumatism, the preparation method of the medicine of gout, comprise the following steps：
（1）Screening crude drug, weighs Semen Strychni 12g, Radix Aconiti 10g, Radix Aconiti Kusnezoffii 14g, Herba Achilleae 13g, Caulis Spatholobi 22g, Ramulus Cinnamomi
8g, Fructus Aurantii 12g, Semen Persicae 13g, Flos Carthami 12g, Lignum Sappan 13g, Radix Angelicae Sinensis 12g, Rhizoma Chuanxiong 13g, Radix Paeoniae Rubra 17g, Radix Bupleuri 8g, Fructus Liquidambaris 12g,
Caulis et Folium piperis 8g, Herba Asari 7g, Radix Gentianae Macrophyllae 8g, Radix Dipsaci 17g, Cortex Eucommiae 8g, Radix Notoginseng 17g, Herba Taxilli 8g, Radix Glycyrrhizae 12g, Agkistrodon 5, four pieces
Watt 22g, Heiguteng exract 18g, Radix Saposhnikoviae 17g；
（2）With 2.7kg, 70 degree alcohol-pickled 6 days, obtains final product.
The above, be only presently preferred embodiments of the present invention, not the present invention is made with any pro forma restriction, appoints
What any is simply repaiied according to what the technical spirit of the present invention made to above example without departing from technical solution of the present invention content
Change, equivalent variations and modification, all still fall within the range of technical solution of the present invention.
Claims (4)
1. the medicine of a kind for the treatment of of arthritis, rheumatism, gout, by weight, including following raw material：
Semen Strychni 8-12 part, Radix Aconiti 10-14 part, Radix Aconiti Kusnezoffii 10-14 part, Herba Achilleae 13-17 part, Caulis Spatholobi 18-22 part, Ramulus Cinnamomi
8-12 part, Fructus Aurantii 8-12 part, Semen Persicae 13-17 part, Flos Carthami 8-12 part, Lignum Sappan 13-17 part, Radix Angelicae Sinensis 8-12 part, Rhizoma Chuanxiong 13-17 part,
Radix Paeoniae Rubra 13-17 part, Radix Bupleuri 8-12 part, Fructus Liquidambaris 8-12 part, Caulis et Folium piperis 8-12 part, Herba Asari 5-7 part, Radix Gentianae Macrophyllae 8-12 part, Radix Dipsaci 13-
17 parts, Cortex Eucommiae 8-12 part, Radix Notoginseng 13-17 part, Herba Taxilli 8-12 part, Radix Glycyrrhizae 8-12 part, Agkistrodon 3, Herba Chloranthi Henryi (Herba Choranthi seu Lysimachiae) 18-22 part,
Heiguteng exract 18-22 part, Radix Saposhnikoviae 13-17 part.
2. the medicine for the treatment of of arthritis according to claim 1, rheumatism, gout, by weight, including following raw material：
10 parts of Semen Strychni, 12 parts of Radix Aconiti, 12 parts of Radix Aconiti Kusnezoffii, 15 parts of Herba Achilleae, 20 parts of Caulis Spatholobi, 10 parts of Ramulus Cinnamomi, 10 parts of Fructus Aurantii,
15 parts of Semen Persicae, 10 parts of Flos Carthami, 15 parts of Lignum Sappan, 10 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Chuanxiong, 15 parts of Radix Paeoniae Rubra, 10 parts of Radix Bupleuri, 10 parts of Fructus Liquidambaris, stone
10 parts of nanmu rattan, 6 parts of Herba Asari, 10 parts of Radix Gentianae Macrophyllae, 15 parts of Radix Dipsaci, 10 parts of the Cortex Eucommiae, 15 parts of Radix Notoginseng, 10 parts of Herba Taxilli, 10 parts of Radix Glycyrrhizae, spend in vain
Serpentiss 2-4 bar, 20 parts of Herba Chloranthi Henryi (Herba Choranthi seu Lysimachiae), 20 parts of Heiguteng exract, 15 parts of Radix Saposhnikoviae.
3. the preparation method of the medicine for the treatment of of arthritis according to claim 1 and 2, rheumatism, gout, walks including following
Suddenly：
（1）Screening crude drug, samples by weight ratio；
（2）With alcohol-pickled 4-6 days of 2300-2700 part 70-80 degree, obtain final product.
4. the medicine for the treatment of of arthritis according to claim 3, rheumatism, gout preparation method it is characterised in that：Step
（2）Described in ethanol be 75 degree.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610946765.3A CN106421045A (en) | 2016-10-26 | 2016-10-26 | Medicine for treating arthritis, rheumatism and metabolic arthritis and preparing method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610946765.3A CN106421045A (en) | 2016-10-26 | 2016-10-26 | Medicine for treating arthritis, rheumatism and metabolic arthritis and preparing method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106421045A true CN106421045A (en) | 2017-02-22 |
Family
ID=58178738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610946765.3A Pending CN106421045A (en) | 2016-10-26 | 2016-10-26 | Medicine for treating arthritis, rheumatism and metabolic arthritis and preparing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106421045A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113491725A (en) * | 2020-04-01 | 2021-10-12 | 张博 | Medicine for treating rheumatism, arthritis and gout |
| CN115389660A (en) * | 2022-08-23 | 2022-11-25 | 南京市六合区中医院 | Traditional Chinese medicine compound composition for treating knee osteoarthritis and quality detection method thereof |
| CN117530976A (en) * | 2023-12-06 | 2024-02-09 | 上海交通大学医学院附属第九人民医院 | Composition and method for treating temporomandibular arthritis |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100998838A (en) * | 2006-12-29 | 2007-07-18 | 张秋霞 | Chinese medicine for relaxing muscles and tendons to promote blood circulation preparation method thereof |
| CN101244252A (en) * | 2008-03-13 | 2008-08-20 | 张金星 | Chinese medicine label for eliminating ache and preparation thereof |
| CN102327479A (en) * | 2011-09-30 | 2012-01-25 | 黄效德 | Plaster for treating hyperosteogeny, rheumatism, rheumatoid arthritis and arthritis |
| CN103550639A (en) * | 2013-10-29 | 2014-02-05 | 陈艺文 | Traditional Chinese medicine medicinal liquor for treating traumatic injury |
| CN104208324A (en) * | 2014-09-11 | 2014-12-17 | 廖天源 | External medicine for treating gall caused by gout, rheumatism and rheumatoid arthritis and preparation method thereof |
| CN105833193A (en) * | 2016-05-19 | 2016-08-10 | 庹朝彦 | Plaster for treating rheumatism |
-
2016
- 2016-10-26 CN CN201610946765.3A patent/CN106421045A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100998838A (en) * | 2006-12-29 | 2007-07-18 | 张秋霞 | Chinese medicine for relaxing muscles and tendons to promote blood circulation preparation method thereof |
| CN101244252A (en) * | 2008-03-13 | 2008-08-20 | 张金星 | Chinese medicine label for eliminating ache and preparation thereof |
| CN102327479A (en) * | 2011-09-30 | 2012-01-25 | 黄效德 | Plaster for treating hyperosteogeny, rheumatism, rheumatoid arthritis and arthritis |
| CN103550639A (en) * | 2013-10-29 | 2014-02-05 | 陈艺文 | Traditional Chinese medicine medicinal liquor for treating traumatic injury |
| CN104208324A (en) * | 2014-09-11 | 2014-12-17 | 廖天源 | External medicine for treating gall caused by gout, rheumatism and rheumatoid arthritis and preparation method thereof |
| CN105833193A (en) * | 2016-05-19 | 2016-08-10 | 庹朝彦 | Plaster for treating rheumatism |
Non-Patent Citations (1)
| Title |
|---|
| 彭成: "《中药毒理学》", 30 April 2014, 北京：中国中医药出版社 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113491725A (en) * | 2020-04-01 | 2021-10-12 | 张博 | Medicine for treating rheumatism, arthritis and gout |
| CN115389660A (en) * | 2022-08-23 | 2022-11-25 | 南京市六合区中医院 | Traditional Chinese medicine compound composition for treating knee osteoarthritis and quality detection method thereof |
| CN115389660B (en) * | 2022-08-23 | 2023-07-14 | 南京市六合区中医院 | Traditional Chinese medicine compound composition for treating knee osteoarthritis and quality detection method thereof |
| CN117530976A (en) * | 2023-12-06 | 2024-02-09 | 上海交通大学医学院附属第九人民医院 | Composition and method for treating temporomandibular arthritis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103784820A (en) | Traditional Chinese medicine formula for treating cariac blood stasis type coronary heart disease | |
| CN101161273B (en) | A Chinese patent medicine for treating catagmat | |
| CN103751497A (en) | Medicament for treating mastitis and preparation method thereof | |
| Zhuang et al. | Interaction between Chinese medicine and digoxin: Clinical and research update | |
| CN106421045A (en) | Medicine for treating arthritis, rheumatism and metabolic arthritis and preparing method thereof | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN106421537A (en) | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition | |
| CN101912577B (en) | Medicament for treating rheumatism and rheumatoid disease and preparation process | |
| CN101284084A (en) | Externally used Chinese medicine for curing hyperosteogeny and protrusion of lumbar intervertebral discs | |
| CN101822798A (en) | Method for preparing tiger-bone wine | |
| CN102309600A (en) | Traditional Chinese medicine prescription for treating acne rosacea | |
| CN102397492A (en) | Medicinal liquor | |
| CN101757259A (en) | Traditional Chinese medicine pill for tonifying kidney, invigorating blood circulation and stimulating menstrual flow | |
| CN101590208B (en) | Medicament composition for treating rheumatoid arthritis, and preparation method thereof | |
| CN1186056C (en) | medicine for treating hyperosteogeny | |
| CN103386085A (en) | Traditional Chinese medicine composition for treating anejaculation | |
| CN107550989A (en) | A kind of Chinese medicine composition for treating rheumatism and preparation method thereof | |
| CN101979057A (en) | Medicine for treating anaphylactoid purpura and preparation method thereof | |
| CN101647897A (en) | Traditional Chinese medicine pill for treating hyperosteogeny | |
| CN105998653A (en) | Medicinal preparation for treating osteonecrosis of femoral head and promoting bone regeneration | |
| CN106421125A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
| CN101485773A (en) | Antiphlogistic and antirheumatic medicament | |
| CN105963660B (en) | A kind of Chinese materia medica preparation for treating rheumatoid arthritis | |
| CN120960373A (en) | Medicine for treating rheumatic diseases and its preparing method | |
| CN101152342A (en) | Chinese medicine for treating bone fracture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170222 |